Evaluating the relationship of high-dose venlafaxine prescribing to treatment-resistant depression

Psychiatric Bulletin

Volumn 27, Issue 3, 2003, Pages 93-95

  Thomas, Arwel ^a   Taylor, David ^a  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGED; ANAMNESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; DOSE RESPONSE; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; PRESCRIPTION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT FAILURE; UNITED KINGDOM;

EID: 0037337883     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.27.3.93     Document Type: Article

References (11)

1. Association of the British Pharmaceutical Industry (2002) Medicines Compendium. London: Datapharm Communications.
2. Clerc, G.E., Ruimy, P & Verdeau-Pailles, J. (1994) A double-blind comparison of venlafaxine and fluoxetine in patients hospitalised for major depression and melancholia. International Clinical Psychopharmacology, 9, 139-143.
3. Dierick, M., Ravizza, L., Realini, R., et al (1996) A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 20, 57-71.
4. Gentil, V., Kerr-Correa, F., Moreno, R., et al (2000) Double blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia. Journal of Psychopharmacology, 14, 61-66.
5. Harvey, A.T., Rudolph, R.L. & Preskorn, S.H. (2000) Evidence of the dual mechanisms of action of venlafaxine. Archives of General Psychiatry, 57, 503-509.
6. Khan, A., Uptong, G.V., Rudolph, R.L., et al (1998) The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: A dose-response study. Journal of Clinical Psychopharmacology, 18, 19-25.
7. Nierenberg, A.A., Feighner, J.P., Rudolph, R., et al (1994) Venlafaxine for treatment-resistant unipolar depression. Journal of Clinical Psychopharmacology, 14, 419-423.
8. Poirier, M.F. & Boyer, P. (1999) Venlafaxine and paroxetine in treatment-resistant depression. Double-blind, randomised comparison. British Journal of Psychiatry, 175, 12-16.
9. Schweizer, E., Weise, C., Clary, C., et al (1991) Placebo-controlled trial of venlafaxine for the treatment of major depression. Journal of Clinical Psychopharmacology, 11, 233-236.
10. Shrivastava, R.K., Cohn, C., Crowder, J., et al (1994) Long term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. Journal of Clinical Psychopharmacology, 14, 322-329.
11. Smith, D., Dempster, C., Glanville, J., et al (2002) Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: A meta-analysis. British Journal of Psychiatry, 180, 396-404.